Shares of Cardlytics (NASDAQ:CDLX) remained unaffected after the company reported Q4 results.
Quarterly Results
Earnings per share decreased 127.78% year over year to ($0.05), which missed the estimate of ($0.03).
Revenue of $67,082,000 decreased by 3.19% year over year, which beat the estimate of $60,890,000.
Outlook
Cardlytics sees Q1 sales of $47 million-$53 million and FY21 sales of $250 million-$275 million.
Details Of The Call
Date: Mar 01, 2021
Time: 08:00 AM
ET Webcast URL: https://edge.media-server.com/mmc/p/kdoe29zt
Recent Stock Performance
52-week high: $161.47
Company's 52-week low was at $27.33
Price action over last quarter: Up 74.32%
Company Description
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
Posted In:
